Hint mode is switched on Switch off

Structure Therapeutics, American depositary receipt (ADR)
GPCR, US86366E1064

Add a stock to WL
Choose all Reset all
Structure Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Structure Therapeutics Inc. is a clinical stage global biopharmaceutical company. The Company focuses on developing oral small molecule therapeutics for the treatment of various diseases including those impacting the metabolic, cardiovascular, and pulmonary systems. Structure Therapeutics ...
Structure Therapeutics Inc. is a clinical stage global biopharmaceutical company. The Company focuses on developing oral small molecule therapeutics for the treatment of various diseases including those impacting the metabolic, cardiovascular, and pulmonary systems. Structure Therapeutics serves customers worldwide.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Structure Therapeutics Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    GPCR
  • Placement
    03.02.2023
  • Lock up period
    180
  • Number of papers
    10,740,000
  • Volume of raised funds
    161.1 mln USD
  • Placement share
    100%
  • Final placement price
    15 USD
  • Price change since placement date
    150.53%
  • By capitalization
    161.1 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    GPCR
  • Placement
    06.06.2024
  • Lock up period
    180
  • Number of papers
    9,066,972
  • Volume of raised funds
    476.02 mln USD
  • Placement share
    16.28%
  • Final placement price
    52.5 USD
  • Price change since placement date
    -28.42%
  • By capitalization
    2,923.5 mln USD

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

07/05/2026 Structure Therapeutics: Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Other Events, Financial Statements And Exhibits
15/04/2026 Structure Therapeutics: Departure Of Director Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
20/01/2026 Structure Therapeutics Inc. (NASDAQ:GPCR) Targets Obesity with Promising Drug
30/12/2025 Structure Therapeutics: Entry Into A Material Definitive Agreement
09/12/2025 Structure Therapeutics: Other Events, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.